Clinical Trial Update: Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases [Phase 3]

View source ↗

Summary

Phase 3 trial comparing 18-minute versus 24-minute UVA exposure in epi-on corneal collagen crosslinking for ectatic corneal diseases, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Ectasia
• Forme Fruste Keratoconus
• Keratoconus
• Pellucid Marginal Degeneration

Snippet

Sponsor: Woolfson Eye Institute | Conditions: Keratoconus, Ectasia of Cornea | Phase 3 | Status: RECRUITING